Pharmaceutical Technology on MSN
Takeda and Protagonist seek FDA approval for rusfertide to treat PV
Takeda and Protagonist Therapeutics have jointly submitted a new drug application (NDA) seeking approval from the US Food and ...
The UK National Screening Committee has opened a 12-week public consultation on whether and how prostate cancer screening ...
Clinical Trials Arena on MSN
Incyte reports positive data from tafasitamab phase III trial for DLBCL
Incyte has reported positive top line data from the pivotal Phase III frontMIND trial assessing the safety and efficacy of ...
Preimplantation genetic testing for aneuploidies does not improve live birth rates in couples undergoing intracytoplasmic ...
Background Inflammatory bowel disease (IBD) patients in China exhibit critically low levels of physical activity, yet evidence for telemedicine-based aerobic exercise interventions remains scarce, ...
HUTCHMED has commenced the Phase III stage of its ongoing Phase II/III clinical trial assessing the combination of ...
Aim To determine if ‘Defocus Incorporated Multiple Segments’ (DIMS) spectacle lenses slow childhood myopia progression. Methods A 2-year double-masked randomised controlled trial was carried out in ...
Objective Anxiety affects up to one-third of adults with asthma and is linked to poorer disease outcomes and reduced quality of life. This study evaluated the efficacy of therapist-guided, ...
Background Complex breast surgery, including immediate breast reconstruction and oncoplastic procedures, is increasingly performed to optimise oncologic and aesthetic outcomes. Postoperative wound ...
Chess960 involves shuffling the pieces at the back of the board, and an analysis suggests doing so can increase the ...
(DAPT) in patients treated with Firehawk stents was non-inferior to 12 months of DAPT for the primary composite event of ...
Its driving physics are chaotically arcadey, and I spent hours zooming over big heaps of snow with a towering pile of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results